| Q39337341 | Autoimmunity in 2016. |
| Q92057326 | Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial |
| Q54795653 | Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease. |
| Q44750823 | Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus |
| Q47939662 | Flares in Chinese systemic lupus erythematosus patients: a 6-year follow-up study |
| Q90415013 | Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies |
| Q60952877 | Fn14 Deficiency Ameliorates Anti-dsDNA IgG-Induced Glomerular Damage in SCID Mice |
| Q47692440 | Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus. |
| Q55378273 | Polymyalgia rheumatica: an autoinflammatory disorder? |
| Q38600390 | Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort. |
| Q64263337 | Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia |
| Q52316454 | Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus. |
| Q50074049 | Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence. |
| Q55318799 | Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature. |
| Q42360078 | Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care |
| Q37402771 | The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus |
| Q39357716 | Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis |